Emerging Technology: Saluda Medical
Part of Advanced Engineering Principles in Neuromodulation: Next-Generation SCS and DBS Technologies
Details
- Date
- Thursday, January 21, 2027
- Time
- 2:40 PM – 2:55 PM
- Session type
- Pre-Conference Session
- Schedule
- See this day
About
This course provides a deep dive into the advanced engineering behind next-generation spinal cord stimulation (SCS) and deep brain stimulation (DBS) technologies. The morning session spotlights academic leaders sharing foundational concepts critical to innovation in neuromodulation, covering topics such as implantable pulse generator design, electrode technology, novel stimulation paradigms, neural sensing, clinical testing strategies, and the integration of artificial intelligence. During the afternoon, you'll gain insider perspectives from engineers at top companies, as they present cutting-edge technologies recently launched or in active development. This unique structure bridges theory and application, empowering attendees with unparalleled insight into both the scientific fundamentals and real-world breakthroughs propelling neuromodulation forward. Each session features a dedicated faculty Q&A, offering direct engagement with experts. The course is tailored for a broad audience: neural engineers, clinicians, industry professionals, and researchers invested in advancing neuromodulation therapies. Attendees will explore the intricate engineering challenges of modern devices, discover emerging solutions and technologies, and understand how academic and industry innovators are shaping the future of patient care. Focused on the most relevant technological advancements and ongoing innovations, this course delivers practical knowledge that can immediately inform clinical decision-making, inspire new research directions, and support technology development in neuromodulation.
Presenters
-
Dean M Karantonis graduated with the BE(Hons)/MBiomedE degree in computer and biomedical engineering from UNSW, Australia. He completed a PhD in biomedical engineering at UNSW in collaboration with industry partner Ventracor, focussed on real-world control of an implantable rotary blood pump. Dr Karantonis was a pivotal member of the NICTA Implant Systems group, which developed a world-first closed-loop neuromodulation technology. He led the engineering development of the Evoke Spinal Cord Stimulation (SCS) System for the treatment of chronic pain at Saluda Medical. From 2017, he led the product development group, during which time the Evoke System was granted its first commercial approvals and was submitted to the FDA. Shifting focus to leveraging Saluda’s core neural sensing technology, he was appointed to lead the newly formed Therapy Development team, and now holds the CTO role, with the team focussed on understanding the neuroscience of chronic pain and other disease states, and using this knowledge and data to create innovative product features, guiding them through feasibility clinical studies and on to product launch. Dr Karantonis has authored numerous journal papers and conference proceedings, coauthored a book chapter on physiological measurement, is a coinventor of numerous patents, and is an IEEE member.